Working together with other universities and disease experts from around the world expands our capabilities in research and discovery. Our unique hub and spoke business model allows for a pipeline of diverse rare and neglected disease projects. This allows CWHM to reach out to others in our field, tackling a variety of rare diseases instead of being locked into a specific area.

Global Collaborations and Partnerships

  • Stlouis University

    Saint Louis University

    Barbara Ulmasov, organ fibrosis
    Brent Tetri, organ fibrosis
    Michael Rauchman, organ fibrosis
    Reggie Aurora, osteogenesis imperfecta (brittle bone disease)
    Dan Hoft, tuberculosis and trypanosome diseases
    Getahun Abate, tuberculosis
    John Tavis, infectious viruses
    Lynda Morrison, infectious viruses
    Adriana Montano, mucopolysaccharidosis newborn screening

  • Washington University

    Washington University

    Jennifer Lodge, cryptococcus neoformans (deadly fungal infections)
    Dan Goldberg, malaria
    John Dipersio, blood cancers and rare genetic blood diseases
    Christina Stallings, tuberculosis
    Brad Warner, infant short gut syndrome

  • Boston University

    Boston University

    Sweta Girgenrath, organ fibrosis

"SLU has a great start scientifically and we're excited to begin a robust collaboration to bring forward what we hope will be the first treatment for this debilitating and progressive disease."

Emil Kakkis, M.D., Ph.D, CEO Ultragenyx Pharmaceuticals